文献速递糖尿病

自动化胰岛素输注与其他1型糖尿病治疗方式在斋月间歇性禁食期间有效性与安全性的真实世界前瞻性研究

A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting.
PubMed 文献 · Diabetes Care · 2024-01-01

该真实世界前瞻性研究纳入294例在2022年斋月尝试禁食的1型糖尿病患者,按治疗方式分为自动胰岛素输注(AID)、常规泵+连续葡萄糖监测(CGM)、泵+自我血糖监测(SMBG)、多次每日注射(MDI)+CGM及MDI+SMBG五组。结果显示AID使用者因糖尿病而破戒的天数中位数最少,目标范围内时间(TIR)最高,且53%达到破戒≤2天且TIR≥70%的双重目标。

要点

  • AID使用者因糖尿病破戒天数中位数为2天,常规泵+CGM为5天,MDI+CGM为3.5天。
  • AID使用者TIR显著高于常规泵和MDI使用者,血糖风险指数、低于范围时间及高于范围时间均更低(均P<0.05)。
  • 53%的AID使用者达到破戒≤2天且TIR≥70%的双重目标,常规泵使用者仅3%,MDI+CGM使用者44%(均P<0.05)。

核心结论

  • 在斋月禁食期间,使用自动胰岛素输注(AID)与最高的禁食完成率和最佳的血糖控制相关。

研究设计与样本

  • 真实世界前瞻性研究,纳入294例在2022年斋月尝试禁食的1型糖尿病患者。
  • 按治疗方式分为五组:AID组(n=62)、常规泵+CGM组(n=37)、泵+SMBG组(n=8)、MDI+CGM组(n=155)、MDI+SMBG组(n=32)。
  • 采用单变量和多变量逻辑回归分析斋月大部分天数禁食(即因糖尿病破戒≤2天)的预测因素。

主要发现

  • 因糖尿病破戒的天数中位数分别为:AID组2天、常规泵+CGM组5天、MDI+CGM组3天、泵+SMBG组3.5天、MDI+SMBG组2.5天(P=0.047)。
  • AID使用者的TIR显著高于常规泵和MDI使用者,血糖风险指数、低于范围时间及高于范围时间显著更低(均P<0.05)。
  • 53%的AID使用者达到破戒≤2天且TIR≥70%的双重目标,常规泵使用者为3%,MDI+CGM使用者为44%(均P<0.05)。
  • 与MDI+CGM使用者相比,AID使用者完成斋月大部分天数禁食的可能性是其两倍。

关键数值与推荐

  • 禁食大部分天数定义为因糖尿病破戒≤2天。
  • 双重目标定义为因糖尿病破戒≤2天且TIR≥70%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the fasting experience and glycemic control during Ramadan among people with type 1 diabetes (PWT1D) who use automated insulin delivery (AID) versus other modalities of treatment. RESEARCH DESIGN AND METHODS: A total of 294 PWT1D who attempted fasting during Ramadan in 2022 were categorized on the basis of treatment modality into one of five groups: 1) AID (n = 62); 2) conventional pump + continuous glucose monitoring (CGM; n = 37); 3) pump + self-monitoring of blood glucose (SMBG; n = 8); 4) multiple daily injections (MDI) + CGM (n = 155); and 5) MDI + SMBG (n = 32). Predictors of fasting most days of Ramadan (i.e., breaking fast ≤2 days because of diabetes) were analyzed using uni- and multivariable logistic regression. RESULTS: The median numbers of days when fasting was broken because of diabetes were 2, 5, 3, 3.5, and 2.5 for AID, conventional pump + CGM, MDI + CGM, pump + SMBG, and MDI + SMBG users, respectively (P = 0.047). Users of AID had a significantly greater time in range (TIR) and lower glycemia risk index, time below range, and time above range compared with users of conventional pumps and MDI (both P < 0.05). Likewise, 53% of AID users attained the double target of 1) breaking fast ≤2 days because of diabetes and 2) maintaining TIR ≥70% during Ramadan compared with only 3% of the conventional pump users and 44% of the MDI + CGM users (both P < 0.05). Compared with MDI + CGM users, AID users were twice as likely to complete fasting most days of Ramadan. CONCLUSIONS: Use of AID is associated with the highest rates of fasting and best glycemic control during Ramadan fasting.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Al-Sofiani ME, Alharthi S, Albunyan S, et al. A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting. Diabetes Care. 2024. PMID: 38290134. doi:10.2337/dc23-1968

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。